Better Coronavirus Stock: Inovio Pharmaceuticals or VBI Vaccines?

Better Coronavirus Stock: Inovio Pharmaceuticals or VBI Vaccines?

Inovio Pharmaceuticals (NASDAQ: INO) is enjoying its best stock performance in seven years thanks to investors' interest in its novel coronavirus vaccine program. VBI Vaccines (NASDAQ: VBIV) appears to be on track for its best year ever -- for the same reason. There are currently 25 COVID-19 vaccine candidates in clinical testing across the world.